ONTARIO, March 22, 2024 — When you buy your tickets today, not only do you have the chance to WIN but you’ll also be helping provide an incredible summer for kids living with the daily agony of arthritis.
For thousands of children living in Canada, summer camp is an opportunity to make friends, have fun outdoors and develop wonderful memories.
Did you ever go to summer camp? If so, you may have fond memories yourself…remember the magic? Singing around the campfire, chatting late at night with your bunkmates, having fun learning new skills, and enjoying the fresh air and summer sun.
Arthritis Society Canada camps are FUN, safe and meaningful for children and teens living with childhood arthritis and other rheumatic diseases.
“My camper has developed a significant needle aversion while undergoing treatment for their arthritis. Going to camp with other kids who are facing the same issues with medication and injections has helped with their sense of perspective, to the necessity and benefits of treatments undertaken.”
– Parent of Camper
Help send even more kids to camp by buying your 50/50 tickets today and you could WIN!
Arthritis Society Canada’s 50/50 Cash Lottery winning ticket will be drawn on April 15, 2024. Don’t miss your chance – get your tickets at arthritis5050.ca now!
Arthritis Society Canada
Arthritis Society Canada is dedicated to extinguishing arthritis. We represent the six million people in Canada living with arthritis today, and the millions more who are impacted or at risk.
Fueled by the trust and support of our donors and volunteers, Arthritis Society Canada is fighting the fire of arthritis with research, advocacy, innovation, information and support.
We are Canada’s largest charitable funder of cutting-edge arthritis research, and we will not give up our efforts until everyone, including the thousands of children living in Canada, are free from the agony of arthritis.
*Currently available for Ontario residents only, must be 18+ to play.
Licence No.: RAF1369037
For questions and more information, please contact [email protected].
Comments are closed.